Anna N. Santoro
Barletta, 70051, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics.
Journal: Expert opinion on drug safety
Published: October 18, 2024
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy.
Journal: Pharmaceutics
Published: August 13, 2024
Antibody-Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?
Journal: Journal of clinical medicine
Published: October 20, 2023
The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions.
Journal: Journal of clinical medicine
Published: August 07, 2023
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
Journal: Life (Basel, Switzerland)
Published: June 07, 2023
Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response.
Journal: Exploration of targeted anti-tumor therapy
Published: May 26, 2023
The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies.
Journal: Pharmaceutics
Published: April 21, 2023
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.
Journal: Current oncology (Toronto, Ont.)
Published: April 18, 2023
Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?
Journal: Expert opinion on pharmacotherapy
Published: April 11, 2023
Tailoring antiHer2 treatment strategies in breast cancer and beyond.
Journal: Current problems in cancer
Published: February 22, 2022
Last Updated: 09/26/2026